APOBEC3B and breast carcinoma: Sieuwerts et al. showed that high APOBEC3B mRNA expression was associated with poor prognosis in ER+ breast cancer, and that high APOBEC3B mRNA expression was an independent prognostic factor in ER+, lymph-node-negative patients [11].